Simon has over six years of professional trading experience across FX, commodities and equities. He has a strong passion for financial markets and is particularly focused on price action trading
Shares of IQ-AI limited (LON: IQAI) today spiked 109.1% higher after the medical imaging company revealed that it had signed a letter of intent to sell its Stonechecker Software Ltd business to an international medical group.
The company revealed that the due diligence process had kicked off and that the deal if completed would include a cash payment and ongoing royalties based on future sales. The company’s StoneChecker is used to assess whether kidney stones will rapture during shockwave treatments.
The company had shifted its focus to its neuroimaging business where it has a strong leadership position in December 2019 and has been looking to offload its Stonechecker business since then.
IQAI share price
The company’s stock price spiked 109% higher to trade at 7.34p having closed yesterday’s session at 3.51p.
CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage . 75 % of retail investor accounts lose money when trading CFDs with this provider . You should consider whether you understand how CFDs work, and whether you can afford to take the high risk of losing your money .